M&A activity will remain moderately strong in both sectors.
A strong first half with blockbuster deals continuing to drive the M&A market in both, life sciences and chemicals. Life sciences shows strong growth prospects in the regenerative medicines market, leading to large deals in gene therapy. Consolidation in paints and coatings drives chemicals M&A. US and China remain the most active countries in life sciences and chemicals.
Browse directly through the publication
© 2019 KPMG AG Wirtschaftsprüfungsgesellschaft, ein Mitglied des KPMG-Netzwerks unabhängiger Mitgliedsfirmen, die KPMG International Cooperative (“KPMG International”), einer juristischen Person schweizerischen Rechts, angeschlossen sind. Alle Rechte vorbehalten.